14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 28, 2023 Sell 1 Thramann Jeffrey John Series A Preferred Stock
Feb 16, 2023 Buy 1 Thramann Jeffrey John Series A Preferred Stock
Dec 29, 2022 Buy 7 711 Ness Brent Common Stock
Dec 29, 2022 Buy 8 500 Ness Brent Common Stock
Dec 29, 2022 Buy 18 304 Lorbiecki John Paul Common Stock
Dec 29, 2022 Buy 4 100 Lorbiecki John Paul Common Stock
Dec 29, 2022 Buy 63 000 Wesemann William Stock option (right to buy)
Dec 28, 2022 Buy 2 289 Ness Brent Common Stock
Dec 02, 2022 Buy 152 128 Neal David K Common Stock
Dec 02, 2022 Sell 1 091 894 Sc Capital 1 Llc Common Stock
Dec 02, 2022 Sell 152 128 Neal David K Common Stock
Apr 22, 2022 Buy 21 000 Bond Ryan Warrants for Common Stock (right to buy)
Apr 22, 2022 Buy 63 000 Sequira Amanda Mae Stock option (right to buy)
Apr 22, 2022 Buy 63 000 Deitsch Stephen Stock option (right to buy)
Apr 22, 2022 Buy 63 000 Deitsch Stephen Stock option (right to buy)
Apr 22, 2022 Buy 63 000 Breidbart Scott Stock option (right to buy)
Apr 21, 2022 Sell 0 Nuvasive Inc Common Stock
Apr 21, 2022 Sell 0 Sc Capital 1 Llc Common Stock
Apr 21, 2022 Sell 9 371 Sc Capital 1 Llc Stock Option (right to buy)
Apr 21, 2022 Buy 11 000 Wesemann William Common Stock
Apr 21, 2022 Buy 11 000 Wesemann William Warrants for Common Stock (right to buy)
Apr 21, 2022 Sell 0 Wesemann William Common Stock
Apr 21, 2022 Sell 10 040 Wesemann William Employee Stock Option (right to buy)
Apr 21, 2022 Buy 1 000 Ness Brent Warrants for Common Stock (right to buy)
Apr 21, 2022 Buy 34 400 Neal David K Warrants for Common Stock (right to buy)
Apr 21, 2022 Buy 0 Nuvasive Inc Common Stock
Apr 21, 2022 Buy 0 Sc Capital 1 Llc Common Stock
Apr 21, 2022 Buy 9 371 Sc Capital 1 Llc Stock Option (right to buy)
Apr 21, 2022 Buy 6 108 Bond Ryan Employee Stock Option (right to buy)
Apr 21, 2022 Buy 21 419 Bond Ryan Employee Stock Option (right to buy)
Apr 21, 2022 Buy 66 934 Lorbiecki John Paul Employee Stock Option (right to buy)
Apr 21, 2022 Buy 10 040 Wesemann William Employee Stock Option (right to buy)
Apr 21, 2022 Buy 66 934 Neal David K Employee Stock Option (right to buy)
Apr 21, 2022 Buy 3 347 Neal David K Employee Stock Option (right to buy)
Apr 21, 2022 Buy 1 204 819 Thramann Jeffrey John Employee Stock Option (right to buy)
Apr 21, 2022 Buy 341 365 Ness Brent Employee Stock Option (right to buy)
Apr 21, 2022 Buy 0 Deitsch Stephen
Apr 21, 2022 Buy 0 Sequira Amanda Mae
Apr 21, 2022 Buy 0 Breidbart Scott
INSIDER POWER
-26.870
Last 39 transactions
Buy: 2 316 770 | Sell: 1 263 434 (Shares)

Based on the 39 latest insides trades, we have calculated the insider power to be negative at a ratio of -26.870.

In total, the insiders bought 2 316 770 441 and sold 1 263 434 ACON shares in the last 39 trades.

Click to get the best stock tips daily for free!

About Aclarion, Inc.

Aclarion. Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclari... ACON Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT